Compare · CAI vs CI
CAI vs CI
Side-by-side comparison of Caris Life Sciences Inc. (CAI) and The Cigna Group (CI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CAI and CI operate in Medical Specialities (Health Care), so they compete in similar markets.
- CI is the larger of the two at $78.07B, about 11.4x CAI ($6.87B).
- Both names hit the wire about 5 times in the past 4 weeks.
- CI has more recent analyst coverage (25 ratings vs 16 for CAI).
- Company
- Caris Life Sciences Inc.
- The Cigna Group
- Price
- -
- -
- Market cap
- $6.87B
- $78.07B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 5
- 5
- Recent ratings
- 16
- 25
Caris Life Sciences Inc.
CAI International, Inc. operates as a transportation finance company in the United States, Switzerland, France, Korea, Singapore, rest of Asia, rest of Europe, and internationally. The company leases, re-leases, and disposes equipment; and contracts for the repair, repositioning, and storage of equipment. It leases its container equipment to lessees under long-term, short-term, and finance leases. The company also sells containers; and manages equipment for to third-party investors, as well as sells used containers. As of December 31, 2020, it had a container fleet comprised 1,798,520 cost equivalent units. The company was formerly known as Container Applications International, Inc. and changed its name to CAI International, Inc. in February 2007. CAI International, Inc. was incorporated in 1989 and is headquartered in San Francisco, California.
The Cigna Group
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U.S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Latest CAI
- Amendment: SEC Form SCHEDULE 13G/A filed by Caris Life Sciences Inc.
- SEC Form 10-Q filed by Caris Life Sciences Inc.
- Caris Life Sciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Caris Life Sciences Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
- Caris Life Sciences Launches New National Commercial Featuring Jordan Spieth Highlighting the Power of Artificial Intelligence in Early Stage Cancer Detection
- Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026
- Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026
- Officer Denton John Russel sold $238,626 worth of shares (7,500 units at $31.82), decreasing direct ownership by 4% to 174,855 units (SEC Form 4)
- Officer Brille Brian J exercised 400,000 shares at a strike of $2.44 and sold $12,132,080 worth of shares (400,000 units at $30.33) (SEC Form 4)
- Caris Life Sciences Inc. filed SEC Form 8-K: Regulation FD Disclosure
Latest CI
- The Cigna Group Announces Appearance at the 2026 UBS Global Healthcare Conference
- SEC Form 10-Q filed by The Cigna Group
- The Cigna Group filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- The Cigna Group Reports Strong Third Quarter 2026 Results, Raises 2026 Outlook
- The Cigna Group Declares Quarterly Dividend
- SEC Form 8-K filed by The Cigna Group
- The Cigna Group's Third Quarter 2026 Earnings Release Details
- Cigna Healthcare Introduces Health Sense To Connect Guidance, Benefits and Clinical Support Around Each Person, Improving Affordability and Outcomes
- The Cigna Group filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- The Cigna Group Hosts 2026 Investor Day; Introduces "Lead to One" to Drive Durable Growth Through Complex Care Leadership and Differentiated Capabilities